Using this approach, we determined that the tyrosine kinase SRC was inactivated after Ki11502 treatment in CRC cells, whereas there was no influence on or even an increase in SRC activation after the down-regulation of PDGFRβ, c-KIT or both using siRNAs. This evidence concerns the gene KIT and colorectal carcinoma.